Overview Request Sample Pages Request Customization Download PDF
You are viewing: India Microfluidics Market analysis
Part of: Microfluidics Market (Global)

The India Microfluidics Market was valued at $1080.98 Million in 2025 and projected to reach to $1833.23 Million by 2030, representing a compound annual growth rate of CAGR 11.1%. India's microfluidics market is poised for substantial growth over the next five years, driven by increasing healthcare expenditure, government support for medical technology innovation, and rising demand for point-of-care diagnostic solutions.

India Microfluidics Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India Microfluidics Market Trends and Insights

  • This represents a compound annual growth rate (CAGR) of 11.1%, significantly outpacing global market expansion.
  • India's healthcare sector is increasingly adopting microfluidic technologies for diagnostics, drug delivery, and point-of-care testing applications, driven by rising healthcare expenditure and government initiatives to modernize medical infrastructure. The microfluidics market in India is benefiting from growing demand for personalized medicine, miniaturized diagnostic devices, and cost-effective healthcare solutions.
  • India's strong pharmaceutical and biotechnology ecosystem, combined with increasing investments in research and development, positions the country as a key growth hub for microfluidic innovations.
  • Between 2025 and 2030, India is expected to witness accelerated adoption across hospitals, diagnostic laboratories, and research institutions, supported by favorable regulatory frameworks and rising awareness of advanced medical technologies..

Key Market Statistics

  • CAGR (2025-2030) CAGR 11.1%
  • Market Size, 2025 ~USD 1080.98 Million
  • Forecast, 2030 ~USD 1833.23 Million
  • Country India

India Microfluidics Market Overview

Strong Growth Trajectory :

India's microfluidics market is growing at 11.1% CAGR, significantly outpacing the global rate of 8.3%, driven by increasing healthcare investments and technological adoption across the country.

Rapid Market Expansion :

The market is projected to grow from USD 1,080.98 million in 2025 to USD 1,833.23 million by 2030, representing a 69.5% increase over five years, reflecting strong demand for advanced diagnostic solutions.

Healthcare Sector Modernization :

India's healthcare industry is increasingly adopting microfluidic technologies for diagnostics, drug delivery systems, and point-of-care testing, driven by government initiatives and rising healthcare awareness.

Emerging Market Opportunity :

With a large population base and growing medical infrastructure, India presents significant opportunities for microfluidics manufacturers and healthcare technology providers seeking expansion in emerging markets.

India Microfluidics Market Dynamics

  • The country's large patient population and expanding healthcare infrastructure create favorable conditions for microfluidic technology adoption across hospitals, diagnostic centers, and research institutions. The market's 11.1% CAGR reflects India's position as a high-growth emerging market in the healthcare technology sector.
  • Key drivers include the adoption of personalized medicine, advancement in drug delivery systems, and the need for cost-effective diagnostic tools.
  • Strategic investments by both domestic and international players, coupled with increasing collaborations between research institutions and industry, are expected to accelerate market penetration and innovation in India's microfluidics landscape..

Related Ecosystem

Analytical And Scientific Instrumentation

Top Technologies
  • Environmental Testing
  • Gas Chromatography
  • Polymerase Chain Reaction (PCR)
  • Automated Liquid Handling Systems
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Shimadzu Corporation
  • Merck KGaA

    Key Takeaways

    • India's microfluidics market is projected to grow from USD 1,080.98 million in 2025 to USD 1,833.23 million by 2030, representing an 11.1% CAGR.
    • India's healthcare modernization initiatives and rising diagnostic demand are driving rapid adoption of microfluidic technologies across the country.
    • India's robust pharmaceutical and biotechnology sector provides a strong foundation for microfluidic innovation and commercialization.
    • Point-of-care testing and personalized medicine applications are emerging as key growth drivers in India's microfluidics market through 2030.

    Microfluidics Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment PCR SYSTEMS (Device)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.3% from 2025 to 2030
    Largest Segment MICROFLUIDICS-BASED DEVICES (Product)
    Market Size Base Year (Billions) ~USD 24.96 (2025)
    Revenue Forecast (Billions) ~USD 37.19 (2030)
    Segments Covered Product, Device, Type, Material, Application, End User

    India Microfluidics Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Microfluidic
    • Microfluidic Components
    • Microfluidics-Based Devices

    By Device

    • Droplet & Particle Production System
    • Droplet & Particle Production Systems
    • Microfluidic Capillary Electrophoresis
    • Next-Generation Sequencing Systems
    • Ngs Systems
    • Other Devices
    • Pcr Systems

    By Type

    • Capillary Electrophoresis
    • Cell-Based Assays
    • Clinical Diagnostics
    • Drug Delivery
    • Flow & Pressure Controllers
    • Flow & Pressure Sensors
    • Genomic Analysis
    • Lab Analytics
    • Microdispensing
    • Microfluidic Chips
    • Microfluidic Valves
    • Microneedles
    • Micropumps
    • Microreactors
    • Other Microfluidic Components
    • Poct
    • Point-Of-Care Testing
    • Proteomic Analysis
    • Veterinary Diagnostics
    • Wearable

    By Material

    • Cyclic Olefin Copolymers
    • Glass
    • Other Materials
    • Polydimethylsiloxane
    • Polymethyl Methacrylate
    • Silicon

    By Application

    • Ivd
    • Pharmaceutical & Life Science Research
    • Therapeutics

    By End User

    • Academic & Research Institutes
    • Hospitals & Diagnostic Centers
    • Pharmaceutical & Biotechnology Companies

    Target Audience

    • Healthcare Device Manufacturers : Manufacturers need India-specific market data to develop localized microfluidic products, understand pricing strategies, and identify distribution channels in this rapidly expanding healthcare market.
    • Diagnostic Companies : Diagnostic firms require detailed insights into India's point-of-care testing adoption rates and market demand to launch targeted solutions and establish partnerships with local healthcare providers.
    • Pharmaceutical & Biotech Companies : Pharma companies need market intelligence on drug delivery microfluidics adoption in India to guide R&D investments, clinical trial planning, and commercialization strategies in this emerging market.
    • Investment & Private Equity Firms : Investors require comprehensive India market analysis to evaluate funding opportunities, assess portfolio company growth potential, and identify emerging microfluidics startups and technology leaders.
    • Healthcare Consultants & Analysts : Consultants need India-focused market data to provide strategic recommendations to clients, support business case development, and guide healthcare technology adoption initiatives across the country.

    Key Companies in the India Microfluidics Market

    CompanyHQOwnershipStrongest segments
    BECKMAN COULTERUnited StatesPrivate CompanyChips,Sensors,Valves,
    RAINDANCE TECHNOLOGIESUnited StatesPrivate CompanyChip,Sensor,Valve,
    HALMA PLCUnited KingdomPublic CompanySensor,Valve,Pump,
    X-FABGermanyPublic CompanyChip,Sensor,Valve,
    TECHNICOLOR SAFrancePublic CompanyChip,Sensor,Valve,
    MAXCYTE, INCUnited StatesPublic CompanyMicrofluidic Chips and Cell-Handling Cartridges (linked to ExPERT PAs),Electroporation Instruments (ExPERT ATx, STx, GTx, VLx),Buffers, Software Protocols, and Accessories,
    DANAHER CORPORATIONUnited StatesPublic CompanyMicrofluidic Chips & Cartridges,Microfluidic Sensors,Microfluidic Valves & Pumps,
    ILLUMINA, INC.United StatesPublic CompanyMicrofluidic Chips (including flow cells and integrated cartridges),Microfluidic Sensors,Microfluidic Valves and Pumps,
    BIOMÉRIEUXFrancePublic CompanyChip,Sensor,Valve,
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyMicrofluidic Chips,Sensors,Valves,
    ABBOTT LABORATORIESUnited StatesPublic CompanyChip,Sensor,Valve,
    PARKER HANNIFIN CORPUnited StatesPublic CompanyValves,Pumps,Sensors,
    SMC CORPORATIONUnited StatesPublic CompanyAI and HPC servers for life-science workloads,Rack-scale solutions for hospital and diagnostic datacenters,Embedded and edge (5G/IoT/Edge) systems,
    IDEX CORPORATIONUnited StatesPublic CompanyPumps,Valves,Sensors,
    FORTIVEUnited StatesPublic CompanyChip-adjacent instrumentation and test,Sensor and pump calibration tools,Sterilization and instrument tracking (microfluidic-enabled devices),
    REVVITY, INC.United StatesPublic CompanyMicrofluidic Chips,Sensors,Valves,
    AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyChip,Sensor,Valve,
    BIO-RAD LABORATORIES, INC.United StatesPublic CompanyChips,Sensors,Valves,
    BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyChip,Sensor,Valve,
    STANDARD BIOTOOLSUnited StatesPublic CompanyMicrofluidic Chips & Consumables,Microfluidic Instruments & Systems,Services, Software & Licensing,

    BECKMAN COULTER

    Beckman Coulter is a United States-based diagnostics and life sciences company founded in 1935 with 11,900 employees. As a private company, it provides laboratory instruments and reagents for clinical and research applications.

    RAINDANCE TECHNOLOGIES

    Raindance Technologies is a United States-based private company founded in 2004 with 104 employees. It develops digital PCR and microfluidic technologies for genomic analysis and molecular diagnostics.

    HALMA PLC

    Halma PLC is a United Kingdom-based public company founded in 1894 with 9,000 employees. It operates as a diversified group providing safety, environmental, and life sciences solutions across multiple markets.

    X-FAB

    X-FAB is a Germany-based public company founded in 1992 with 4,300 employees. It is a specialty semiconductor foundry providing analog and mixed-signal semiconductor manufacturing services.

    TECHNICOLOR SA

    Technicolor SA is a France-based public company founded in 1985 with 1,552 employees. It provides media and entertainment technology services including post-production, digital cinema, and content delivery solutions.

    MAXCYTE, INC

    MaxCyte, Inc. is a United States-based public company founded in 1998 with 91 employees. It develops electroporation technology platforms for cell engineering and therapeutic applications.

    DANAHER CORPORATION

    Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees. It operates as a diversified conglomerate providing products and services in life sciences, diagnostics, environmental, and applied solutions.

    ILLUMINA, INC.

    Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees. It is a leading provider of DNA sequencing and array-based solutions for genomic analysis.

    BIOMÉRIEUX

    bioMérieux is a France-based public company founded in 1963 with 14,894 employees. It specializes in in vitro diagnostics and microbiology testing solutions for clinical and industrial applications.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. It is a global leader in serving science, providing laboratory equipment, reagents, software, and services for research and diagnostics.

    ABBOTT LABORATORIES

    Abbott Laboratories is a United States-based public company founded in 1888 with 115,000 employees. It is a diversified healthcare company providing pharmaceuticals, diagnostics, nutritional products, and medical devices.

    PARKER HANNIFIN CORP

    Parker Hannifin Corp is a United States-based public company founded in 1917 with 57,950 employees. It manufactures motion and control technologies including hydraulic, pneumatic, and electromechanical systems.

    SMC CORPORATION

    SMC Corporation is a United States-based public company founded in 1993 with 6,238 employees. It manufactures pneumatic and electric automation components and systems for industrial applications.

    IDEX CORPORATION

    IDEX Corporation is a United States-based public company founded in 1987 with 8,700 employees. It provides fluid and metering technologies, dispensing equipment, and safety systems for various industrial and life sciences applications.

    FORTIVE

    Fortive is a United States-based public company founded in 2015 with 10,000 employees. It operates as a diversified industrial technology conglomerate providing software, services, and equipment for manufacturing and infrastructure.

    REVVITY, INC.

    Revvity, Inc. is a United States-based public company founded in 1937 with 11,000 employees. It provides analytical instruments, software, and services for life sciences research, diagnostics, and environmental testing.

    AGILENT TECHNOLOGIES, INC.

    Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees. It provides analytical instruments, software, and services for life sciences, diagnostics, and chemical analysis.

    BIO-RAD LABORATORIES, INC.

    Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. It manufactures and distributes life science research products and clinical diagnostics solutions.

    BECTON, DICKINSON AND COMPANY

    Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees. It is a global medical technology company providing medical devices, laboratory equipment, and diagnostic products.

    STANDARD BIOTOOLS

    Standard Biotools is a United States-based public company founded in 1999 with 387 employees. It develops microfluidic and single-cell analysis technologies for life sciences research and diagnostics.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise valuation figures for India's microfluidics market (2025-2030) with detailed CAGR analysis, enabling accurate financial forecasting and investment decision-making for your business strategy.
    • Competitive Positioning : Understand India's market dynamics relative to global trends, identifying growth opportunities and competitive advantages specific to the Indian healthcare microfluidics sector for strategic planning.
    • Sector-Specific Insights : Gain detailed intelligence on microfluidic applications in diagnostics, drug delivery, and point-of-care testing within India's healthcare ecosystem to tailor product development and market entry strategies.
    • Investment & Expansion Planning : Leverage comprehensive India-focused market data to evaluate expansion opportunities, identify high-potential segments, and make informed decisions about resource allocation in this high-growth emerging market.
    • Regulatory & Infrastructure Context : Understand India's healthcare infrastructure development and technology adoption patterns to align your microfluidics solutions with local market needs and regulatory requirements.

    Frequently asked questions

    What is the current size of India's microfluidics market?

    India's microfluidics market was valued at USD 1,080.98 million in 2025 and is expected to reach USD 1,833.23 million by 2030.

    What is the projected growth rate for microfluidics in India?

    India's microfluidics market is projected to grow at a compound annual growth rate (CAGR) of 11.1% from 2025 to 2030.

    Which applications are driving microfluidics adoption in India?

    Key applications driving India's microfluidics market include point-of-care diagnostics, drug delivery systems, personalized medicine, and laboratory-on-chip technologies.

    What factors are accelerating microfluidics market growth in India?

    India's microfluidics growth is driven by healthcare modernization initiatives, rising diagnostic demand, government support for medical innovation, and the country's strong pharmaceutical ecosystem.

    How does India's microfluidics market compare to global trends?

    India's microfluidics market is growing at 11.1% CAGR, outpacing the global market growth rate of 8.3%, reflecting strong regional demand and investment momentum.

    RESEARCH METHODOLOGY

    Four main studies were done to estimate the market size of microfluidics. Secondary research was carried out to obtain data associated with the market, peer markets, and parent markets. After that, data was obtained from 3-5 secondary sources; the findings, assumptions, and sizing were confirmed through primary sources. Top-down and bottom-up approaches were utilized to gain insights on complete market size. After that, market breakdown and data triangulation were used to determine the market size of segments and subsegments.

    Secondary Research

    Directories, databases like D&B Hoovers, Factiva, white papers, Bloomberg Businessweek, annual reports, SEC filings, business filings and investor presentations are few of the important sources used in the secondary research. This helps in gaining fundamental details about prominent companies and market segmentation as per the industry trends at numerous levels and technological viewpoints related with the Microfluidics market.

    Primary Research

    The primary research compromised performing interviews from both the supply and demand sides to obtain quantitative and qualitative data. CEOs, area sales managers, territory sales managers, regional sales managers and other important officials from top businesses are the primary sources from the supply side. Physicians, researchers, department heads, and staff members from diagnostic centers, hospitals and research institutes were the primary sources from the demand side. The target of this study was to verify the conclusions and assumptions from secondary research by interacting with stakeholders directly.

    A breakdown of the primary respondents is provided below:

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The revenue share analysis of the major key players for the size of the Microfluidics market is given in this study. Primary and secondary research are used to find prominent players in the Microfluidics and to gain insights of their financials and market share. The primary research approach comprises extremely in-depth interviews with CEOs, directors, and senior marketing executives, while the secondary research procedure mostly relied on the annual and financial reports of major players. Segment-based technique was used to determine the global market value. The revenue details of significant solution and service suppliers was then applied to source these segmented revenues.

    The steps in the procedure  are

    • List the key global companies that are associated with the Microfluidics industry. Note the annual revenues of the players in the Microfluidics industry or the product category/business division.
    • As of 2024, it represents an important portion of the market based on revenue mapping of the key competitors. Extrapolation to the global value for the Microfluidics market.

    Data Triangulation

    The Microfluidics market was categorized into various segments and subsegments with the help of the above procedure. Then, data triangulation and the market segmentation process are carried out to ensure the accuracy of the data for each segment. Factors and trends from demand and supply sides were studied . Top-down and bottom-up approaches provide the outcome from the analysis of the Microfluidics market.

    Market Definition

    The microfluidics market includes products and technologies that are developed to analyse and regulate fluid volume through microfluidic devices and components. The market covers both the microfluidics components that are important for the working of microfluidics-based devices, such as lab-on-a-chip systems and diagnostic assays, as well as the devices. Microneedles, micropumps, flow and pressure sensors, controllers, and microfluidic valves are some of the important components of microfluidics-based device.Polymers, silicon, and glass are most often used in the development of these components. The market provides innovative technologies for effective and precise fluid management and analysis, which have beneficial applications in research and diagnostics.

    Stakeholders

    • Microfluidic product manufacturers
    • Microfluidic product distributors
    • Pharmaceutical companies
    • IVD manufacturers
    • In vitro diagnostic test (IVD) distributors
    • Research institutes
    • Contract manufacturing organizations (CMOs)
    • Contract research organizations (CROs)
    • Healthcare institutions (hospitals, medical schools, and outpatient clinics)
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors

    Report Objectives

    • To define, describe, and forecast the microfluidics market by product, application, end-user, and region
    • To provide detailed information about the key factors influencing the market growth, such as drivers, restraints, opportunities, challenges, and industry trends
    • To strategically analyze the regulatory scenario, Porter’s five force analysis, value chain analysis, supply chain analysis, ecosystem map, and patent analysis
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the microfluidics market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To profile the prominent players in this market and comprehensively analyze their market shares and core competencies
    • To strategically analyze the microfluidics market in five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To track and analyze competitive developments such as acquisitions, product launches, product approvals, partnerships, and expansions in the microfluidics market

     

    Get the Full Microfluidics Market Report

    Full forecast, segment splits, and company analysis for all Microfluidics Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status